Aspirin dose for prevention of cardiovascular disease in diabetics - Wikidata - wikimedia - TriplyDB

Aspirin dose for prevention of cardiovascular disease in diabetics

Aspirin dose for prevention of cardiovascular disease in diabetics

http://www.wikidata.org/entity/Q28194526

about

sameAs

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

P2860

Q28222880-0D7239AB-8E16-4274-81E0-E0FBE8DF22B4 Q42584252-AAB27960-4EB4-4AAB-97CC-3136DBD9D301

P2860

Aspirin dose for prevention of cardiovascular disease in diabetics

http://www.wikidata.org/entity/Q28194526

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Aspirin dose for prevention of cardiovascular disease in diabetics

@ast

Aspirin dose for prevention of cardiovascular disease in diabetics

@en

Aspirin dose for prevention of cardiovascular disease in diabetics

@nl

type

label

Aspirin dose for prevention of cardiovascular disease in diabetics

@ast

Aspirin dose for prevention of cardiovascular disease in diabetics

@en

Aspirin dose for prevention of cardiovascular disease in diabetics

@nl

prefLabel

Aspirin dose for prevention of cardiovascular disease in diabetics

@ast

Aspirin dose for prevention of cardiovascular disease in diabetics

@en

Aspirin dose for prevention of cardiovascular disease in diabetics

@nl

P1433

Q28194526-8CDB1E6A-0E65-484A-A9B0-1C635A490D30

P1476

Q28194526-B732949A-2AF0-4624-8820-497C15D8B399

P2093

Q28194526-800B1592-9103-4772-87A9-F26C2AA63623

Q28194526-E0747F5B-C5D2-4EBD-8F57-7611EB90E780

P2860

Q28194526-02AEB74A-998D-422E-9665-73AB6C3DF517

Q28194526-0C6C9FFD-67B9-4795-BF03-A042C51AA953

Q28194526-1ECE76DB-A90D-49AF-918B-2CAB2CC54341

Q28194526-2E890878-E666-429F-9E59-5E6C1A86CD18

Q28194526-30831D8D-80A0-4AFF-87CC-460FFDC3E8D9

Q28194526-6042ACE0-F24C-4A7E-861B-86C14703780D

Q28194526-6044A82C-12C5-4146-8D6A-85759777CEC2

Q28194526-7EDBA713-DAFE-4707-AA26-BE2D7A52E5A1

Q28194526-898C0C64-0129-4823-AEFF-8616A30E77A9

Q28194526-9988CF12-23FB-448D-A1D5-777603F2EF15

P304

Q28194526-E0393D93-E329-49D0-B7AE-019743FF7730

P31

Q28194526-FAB48F07-B53C-4661-A247-047048E342F3

P356

Q28194526-03DA532C-A9D1-4A84-8DE8-57BCFCB81975

P407

Q28194526-F5528221-82F7-4DF9-A634-7CACFD7967F5

P433

Q28194526-CDB65E40-C4AD-4E0E-8E7D-921DDB01D26C

P478

Q28194526-F97DA4EF-96C6-45D1-AA19-3C8F96ECD589

P577

Q28194526-E325A1B3-8B5C-438B-B0DC-7BFA8DF6477E

P698

Q28194526-D4335C28-D96A-4599-BF90-8D08DBFCFEFF

P921

Q28194526-19451380-3C0A-43CB-BACF-4A4B8547BB28

Q28194526-E6C3C790-30BA-483E-A2CD-8E54248AA5E4

P356

P1433

Annals of Pharmacotherapy

P1476

Aspirin dose for prevention of cardiovascular disease in diabetics

@en

P2093

Linda A Jaber

http://www.w3.org/2001/XMLSchema#string

Sandra N Nowak

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

Blood coagulation at the site of microvascular injury: effects of low-dose aspirin

Treatment for the procoagulant state in type 2 diabetes

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Final report on the aspirin component of the ongoing Physicians' Health Study

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Platelet dysfunction in type 2 diabetes.

P304

116-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1C101

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12503945

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease